Comparison of MISR2 expression in patient and successive passages of patient-derived xenografts of ovarian cancer

Gill, Sarah

337
Comparison of MISR2 expression in patient and successive passages of patient-derived xenografts of ovarian cancer

Saturday, March 28, 2015: 9:55 AM

Salon C-D (Hilton Chicago)

S. Gill¹, Q. Zhang¹, P. Haluska Jr.¹, J. N. Bakkum-Gamez², B. A. Cliby² and S. J. Weroha²
¹Mayo Clinic College of Medicine, Rochester, MN, ²Mayo Clinic, Rochester, MN

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

337
Comparison of MISR2 expression in patient and successive passages of patient-derived xenografts of ovarian cancer

337 Comparison of MISR2 expression in patient and successive passages of patient-derived xenografts of ovarian cancer

337
Comparison of MISR2 expression in patient and successive passages of patient-derived xenografts of ovarian cancer